Questions about pharma pricing and marketing
In 2017, Allergan CEO Brent Saunders promised to reign in drug price hikes, and other Pharma companies followed suit. In 2021, it looks like all bets are off.
In August, Amgen raised the price of its psoriasis med Otezla by 2.4 percent after raising the price of its oncology biologic Mvasi and chronic kidney disease med Parsabiv by 3 percent, reports FiercePharma. Merck similarly Read more…
Questions about pharma pricing and marketing









![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)




![True metabolic healing requires more than just prescribing expensive peptides [PODCAST]](https://kevinmd.com/wp-content/uploads/bac3c442-618d-4603-944d-2f94e78ad46b-190x100.jpeg)

